Greeting from CEO

Dr. Yasumasa Goh, CEO
These new type pharmaceuticals, including old-type ones, however, has many side effects because the active substance act to normal tissues or organs. Nucleotide drugs that are enthusiastically expected as a next generation drug, has several weakness to be used as a drug; i.e., they are easily degraded in blood stream as a free form, and it is difficult to deliver enough amount to targeted tissue without causing dispersion.
Because of these problems, the importance of drug deliver system is increasing in recent years.
Beacle’s mission is to concentrate our effort to develop DDS system using a very unique “Bio-nanocapsule” technology in order to serve people’s health.